Medgadget

SEPTEMBER 29, 2023

This layer of specialized endothelium significantly restricts which drug molecules can enter the brain, normally greatly limiting treatment options for patients with brain-based disease. CraniUS , a medtech company based in Baltimore, has developed the NeuroPASS drug delivery system.

Medicine 105

Medicine Distribution Specialization Medical 105

Contrarian Sales Techniques

FEBRUARY 24, 2023

RM1 billion will be allocated to strengthen domestic safety, including acquiring more than 2,100 units of body cameras for the Royal Malaysia Police. The Green Technology Financing Scheme (GTFS) is improved, with the guaranteed value increased to RM3 billion until 2025. RM1 billion in loans to help improve local food production.

Government 52

Government Education Medical sales reps Food 52

pharmaphorum

DECEMBER 14, 2022

In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Two decades of exclusivity. The best-case scenario? The last patent currently in litigation is Jazz’s REMS program.

Competition 95

Competition FDA Pharmaceutical Marketing 95

European Pharmaceutical Review

DECEMBER 19, 2023

16 Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions” Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions. Injection Safety Fact Sheet. at 100°C for 24 hours.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111

Pharmaceutical Technology

JULY 29, 2022

On 25 June, Pfizer and BioNTech (Mainz, Germany) reported pivotal Phase II/III data demonstrating the safety, tolerability and immunogenicity of two Omicron-adapted vaccine candidates. Jubilant will double its injectable filling capacity in Spokane at a cost of $193m, to be completed by 2025. with BARDA (Washington DC).

Manufacturing 52

Manufacturing Food and Drug Administration Marketing FDA 52

European Pharmaceutical Review

FEBRUARY 7, 2023

From 31 January 2025, new and ongoing clinical trials in the EU must be conducted in compliance with the CTR. In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. Authorisation of the clinical trial, may, however, be obtained later.

Medical 117

Medical Government Marketing Medicine 117

Rep-Lite

JULY 27, 2023

billion by 2025. Navigating Regulatory Changes and Compliance The medical device industry operates under strict regulations to ensure patient safety. Rep-Lite, a leading recruitment agency specializing in medical device sales, has a proven track record of matching top-tier sales professionals with leading medical device companies.

Sales 52

Sales Medical Medical sales Sales Strategy 52